In vivo tumour and metastasis reduction and in vitro effects on invasion assays of the ruthenium RM175 and osmium AFAP51 organometallics in the mammary cancer model

Journal of Inorganic Biochemistry

Volumn 104, Issue 1, 2010, Pages 79-86

  Bergamo, A ^a   Masi, A ^a   Peacock, A F A ^b   Habtemariam, A ^c   Sadler, P J ^c   Sava, G ^a,d  

^a Callerio Foundation   (Italy)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Invasion; Mammary cancer; Metastasis; Organometallic; Osmium; Ruthenium

Indexed keywords

AFAP 51; COLLAGEN TYPE 4; FIBRONECTIN; GELATINASE A; HUMAN SERUM ALBUMIN; LIGAND; MATRIX METALLOPROTEINASE; ORGANOMETALLIC COMPOUND; OSMIUM DERIVATIVE; POLYLYSINE; RM 175; RUTHENIUM COMPLEX; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CANCER MODEL; CELL ADHESION; CELL MIGRATION; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DRUG STRUCTURE; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; METASTASIS; NONHUMAN; PRIMARY TUMOR; TUMOR; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; HUMANS; MATRIX METALLOPROTEINASES; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ORGANOMETALLIC COMPOUNDS; OSMIUM; RUTHENIUM;

EID: 70449687713     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2009.10.005     Document Type: Article

References (33)

1. Wang D., and Lippard S.J. Nat. Rev. Drug Discov. 4 (2005) 307-320
2. Bruijnincx P.C.A., and Sadler P.J. Curr. Opin. Chem. Biol. 12 (2008) 197-206
3. Ronconi L., and Sadler P.J. Coord. Chem. Rev. 251 (2007) 1633-1648
4. Yan Y.-K., Melchart M., Habtemariam A., and Sadler P.J. Chem. Commun. (2005) 4764-4776
5. Dougan S.J., and Sadler P.J. CHIMIA Int. J. Chem. 61 (2007) 704-715
6. Rademaker-Lakhai J.M., van den Bongard D., Pluim D., Beijnen J.H., and Schellens J.H. Clin. Cancer Res. 10 (2004) 3717-3727
7. Hartinger C.G., Jakupec M.A., Zorbas-Seifried S., Groessl M., Egger A., Berger W., Zorbas H., Dyson P.J., and Keppler B.K. Chem. Biodivers. 5 (2008) 2140-2155
8. Hartinger C.G., Zorbas-Seifried S., Jakupec M.A., Kynast B., Zorbas H., and Keppler B.K. J. Inorg. Biochem. 100 (2006) 891-904
9. Alessio E., Mestroni G., Bergamo A., and Sava G. In: Sigel A., and Sigel H. (Eds). Metal Ions in Biological Systems. Metal Complexes in Tumor Diagnosis and As Anticancer Agents (2004), Marcel Dekker Inc., New York 323-351
10. Clarke M.J. Coord. Chem. Rev. 236 (2003) 209-233
11. Morris R.E., E Aird R., Murdoch P.D.S., Chen H., Cummings J., Huges N.D., Parsons S., Parkin A., Boyd G., Jodrell D.I., and Sadler P.J. J. Med. Chem. 44 (2001) 3616-3621
12. Aird R.E., Cummings J., Ritchie A.A., Muir M., Morris R.E., Chen H., Sadler P.J., and Jodrell D.I. Br. J. Cancer 86 (2002) 1652-1657
13. Habtemariam A., Melchart M., Fernández R., Parsons S., Oswald I.D.H., Parkin A., Fabbiani F.P.A., Davidson J.E., Dawson A., Aird R.E., Jodrell D.I., and Sadler P.J. J. Med. Chem. 49 (2006) 6858-6868
14. Hayward R., Schornagel Q., Tente R., Macpherson J., Aird R., Guichard S., Habtemariam A., Sadler P.J., and Jodrell D.I. Cancer Chemother. Pharmacol. 55 (2005) 577-583
15. Guichard S.M., Else R., Reid E., Zeitlin B., Aird R., Muir M., Dodds M., Fiebig H., Sadler P.J., and Jodrell D.I. Biochem. Pharmacol. 71 (2006) 408-415
16. Peacock A.F.A., and Sadler P.J. Chem. Asian J. 3 (2008) 1890-1899
17. Peacock A.F.A., Habtermariam A., Fernández R., Walland V., Fabbiani F.P., Parsons S., Aird R.E., Jodrell D.I., and Sadler P.J. J. Am. Chem. Soc. 128 (2006) 1739-1748
18. Peacock A.F.A., Habtermariam A., Moggach S., Prescimone A., Parsons S., and Sadler P.J. Inorg. Chem. 44 (2007) 4049-4059
19. Kostrhunova H., Florian J., Novakova O., Peacock A.F.A., Sadler P.J., and Brabec V. J. Med. Chem. 51 (2008) 3635-3643
20. Chen H., Parkinson J.A., Parsons S., Coxall R.A., Gould R.O., and Sadler P.J. J. Am. Chem. Soc. 124 (2002) 3064-3082
21. Skehan P., Soreng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren J.T., Bokesch H., Kennet S., and Boyd M.R. J. Natl. Cancer Inst. 82 (1990) 1107-1112
22. Albini A., Iwamoto Y., Kleinman K., Martin G.R., Aaronson S.A., Kozlowski J.M., and McEwan R.N. Cancer Res. 47 (1987) 3239-3245
23. Kueng W., Silber E., and Eppenberger U. Anal. Biochem. 182 (1989) 16-19
24. Alley M.C., Scudiero D.A., Monks A., Hursey M.L., Czerwinski M.J., Fine D.L., Abbott B.J., Mayo J.G., and Shoemaker R.H. Cancer Res. 48 (1988) 589-601
25. Bradford M.M. Anal. Biochem. 72 (1976) 248-254
26. Jamieson E.R., and Lippard S.J. Chem. Rev. 99 (1999) 2467-2498
27. Wang F., Habtemariam A., van der Geer E.P.L., Fernández R., Melchart M., Deeth R.J., Aird R., Guichard S., Fabbiani F.P.A., Lozano-Casal P., Oswald I.D.H., Jodrell D.I., Parsons S., and Sadler P.J. Proc. Natl. Acad. Sci. USA 102 (2005) 18269-18274
28. Chen H., Parkinson J.A., Morris R.E., and Sadler P.J. J. Am. Chem. Soc. 125 (2003) 173-186
29. Liu H.-K., Berners-Price S.J., Wang F., Parkinson J.A., Xu J., Bella J., and Sadler P.J. Angew. Chem. Int. Ed. 45 (2006) 8153-8156
30. Meggers E. Chem. Commun. (2009) 10.1039/b813568a
31. Novakova O., Chen H., Vrana O., Rodger A., Sadler P.J., and Brabec V. Biochemistry 42 (2003) 11544-11554
32. Peacock A.F.A., Parsons S., and Sadler P.J. J. Am. Chem. Soc. 129 (2007) 3348-3357
33. van Rijt S.H., Peacock A.F.A., Johnstone R.D.L., Parsons S., and Sadler P.J. Inorg. Chem. 48 (2009) 1753-1762